Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations
- 21 December 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Familial Cancer
- Vol. 11 (2), 235-242
- https://doi.org/10.1007/s10689-011-9506-2
Abstract
The risks of cancers other than breast and ovarian amongst BRCA1 and BRCA2 mutation carriers are based on relatively few family based studies with the risk of specific cancers tested in population based samples of cancers from founder populations. We assessed risks of “other cancers” in 268 BRCA1 families and 222 BRCA2 families using a person years at risk analysis from 1975 to 2005. Cancer confirmations were overall higher than in previous family based studies at 64%. There was no overall increase in risk for BRCA1 carriers although oesophagus had a significant increased RR of 2.9 (95% CI 1.1–6.0) and stomach at 2.4 (95% CI 1.2–4.3), these were based mainly on unconfirmed cases. For BRCA2 increased risks for cancers of the pancreas (RR 4.1, 95% CI 1.9–7.8) and prostate (RR 6.3, 95% CI 4.3–9.0) and uveal melanoma (RR 99.4, 95% CI 11.1–359.8) were confirmed. Possible new associations with oesophagus (RR 4.1, 95% CI 1.9–7.8) and stomach (RR 2.7, 95% CI 1.3–4.8) were detected but these findings should be treated with caution due to lower confirmation rates. In contrast to previous research a higher risk of prostate cancer was found in males with mutations in the BRCA2 OCCR region. The present study strengthens the known links between BRCA2 and pancreatic and prostate cancer, but throws further doubt onto any association with BRCA1. New associations with upper gastro-intestinal malignancy need to be treated with caution and confirmed by large prospective studies.Keywords
This publication has 27 references indexed in Scilit:
- BRCA Germline Mutations in Jewish Patients With Pancreatic AdenocarcinomaJournal of Clinical Oncology, 2009
- Penetrance estimates for BRCA1 and BRCA2based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the familyBMC Cancer, 2008
- Germline BRCA2 mutations and the risk of esophageal squamous cell carcinomaOncogene, 2007
- Cancer risks in BRCA2 families: estimates for sites other than breast and ovaryJournal of Medical Genetics, 2005
- Contribution of Germline Mutations inBRCA2,P16INK4A,P14ARFandP15to Uveal MelanomaInvestigative Ophthalmology & Visual Science, 2003
- Cancer risks in BRCA1 carriers: time for the next generation of studies.JNCI Journal of the National Cancer Institute, 2002
- Cancer Incidence in BRCA1 Mutation CarriersJNCI Journal of the National Cancer Institute, 2002
- Cancer Risks in BRCA2 Mutation CarriersJNCI Journal of the National Cancer Institute, 1999
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsThe New England Journal of Medicine, 1997